Polar Asset Management Partners’s European Biotech Acquisition Corp. Class A Ordinary Shares EBAC Stock Holding History

Polar Asset Management Partners’s Portfolio EBAC Stock Details EBAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-46,500	Closed	-$470K	–	1295
2022 Q4	$470K	Hold	46,500	–	–	0.01%	737
2022 Q3	$461K	Hold	46,500	–	–	0.01%	817
2022 Q2	$455K	Buy	+46,500	New	+$455K	0.01%	804

Polar Asset Management Partners's EBAC Position: Q1 2023 in Review

Polar Asset Management Partners sold out of European Biotech Acquisition Corp. Class A Ordinary Shares (EBAC) in Q1 2023, closing a stake of 46,500 shares — an estimated $470K sold.

Polar Asset Management Partners first reported a position in EBAC in Q2 2022 and held it in 3 quarters. The position peaked at $470K in Q4 2022. 0 funds tracked by Wall St. Rank hold EBAC as of Q1 2023.

Polar Asset Management Partners reported no remaining European Biotech Acquisition Corp. Class A Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Polar Asset Management Partners sold 46,500 European Biotech Acquisition Corp. Class A Ordinary Shares shares in Q1 2023, an estimated $470K.
Polar Asset Management Partners first reported a position in European Biotech Acquisition Corp. Class A Ordinary Shares in Q2 2022 and held it in 3 quarters.
Polar Asset Management Partners's European Biotech Acquisition Corp. Class A Ordinary Shares position peaked at $470K in Q4 2022.
0 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Class A Ordinary Shares as of Q1 2023.

Based on Polar Asset Management Partners's 13F filing for Q1 2023, filed 15 May 2023.